Aptima combo 2, 250-test kit, panther
Ended Purchase Order Awarded Last action
- Contract number
- W81K0015P0967
- Awardee
-
Gen-Probe Incorporated UEI QNXWLAJDL4J3
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $0
Award facts
- Opportunity
-
- W81K0015T0078 Solicitation number
- Cost-per-reportable-result (CPRR) arrangement for San Antonio Military Medical Center (SAMMC), Fort Sam Houston, Texas Award Notice · Posted Aug 18, 2015
- Contract value 0% obligated
- $1,265,955.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 2 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92121, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $0 | |
| Exercise an Option | $0 | |
| Funding Only Action | $0 | |
| Exercise an Option | $0 | |
| Funding Only Action | $0 | |
| Original award | $0 |
About this award
This federal contract award, valued at $1,265,955.00, was issued by the United States Army Medical Command (MEDCOM) to Gen-Probe Incorporated, a medical diagnostics company, for the procurement of APTIMA COMBO 2, 250-TEST KIT, PANTHER systems. The contract is a firm fixed-price purchase order with a completion date of September 30, 2018. Gen-Probe Incorporated is a prime contractor that has held numerous contracts with defense and civilian agencies, primarily supplying testing kits, reagents, and equipment for detecting infectious diseases such as HIV, hepatitis C, sexually transmitted infections, and COVID-19. This contract award is not associated with a set-aside designation. The contract is part of Gen-Probe's broader work with federal agencies, including the Department of the Army Medical Command, Department of Veterans Affairs, and Department of the Navy Bureau of Medicine and Surgery, to provide critical molecular diagnostic products and services to support ongoing healthcare and pandemic response efforts for military personnel, veterans, and their families.
Quick answers
Who was awarded contract W81K0015P0967?
W81K0015P0967 was awarded to Gen-Probe Incorporated by Medical Command (Department of the Army) on October 1, 2015.
How much is contract W81K0015P0967 worth?
The government has obligated $0 on W81K0015P0967. Its current value, with exercised options, is $1,265,955.
Was contract W81K0015P0967 competed?
The extent of competition for W81K0015P0967 was competed under sap. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award